INS and metabolic dysfunction-associated steatotic liver disease: Because of the high incidence of NAFLD in obese subjects, presenting a mild diffuse inflammation that affects insulin signaling and leads to insulin resistance (IR), recently NAFLD has been proposed to constitute the hepatic component of metabolic syndrome, featuring a metabolic derangement of the whole organism [7,8].